XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating expenses        
Research and development $ 13,297 $ 8,135 $ 23,102 $ 16,323
General and administrative 4,530 3,828 8,672 8,418
Total operating expenses 17,827 11,963 31,774 24,741
Loss from operations (17,827) (11,963) (31,774) (24,741)
Interest income 1,436 92 2,532 94
Change in fair value of earnout liability 420 625 (344) 5,218
Change in fair value of common stock warrant liability 845 (575) 6,895
Other expense, net (109) (3) (179) (77)
Total other income, net 1,747 1,559 1,434 12,130
Net loss and comprehensive loss $ (16,080) $ (10,404) $ (30,340) $ (12,611)
Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share) $ (0.15) $ (0.29) $ (0.31) $ (0.35)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in Shares) 109,213,669 36,397,822 98,605,265 36,353,509